About Think Bioscience
Think Bioscience is a company based in Boulder (United States) founded in 2019 by Jerome Fox and Philip Jeng. Think Bioscience has raised $78 million across 4 funding rounds from investors including YK Bioventures, America’s Seed Fund and Innovation Endeavors. The company has 21 employees. Think Bioscience offers products and services including Small-Molecule Drugs and Synthetic Biology Platform. Think Bioscience operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter Boulder, United States
- Employees 21
- Founders Jerome Fox, Philip Jeng
- SectorsHealthcare
- Email••••••••
- Website thinkbioscience.com
- Social LinkedIn X
- Legal Name Think Bioscience, Inc.
- Total Equity Funding$78M (USD)
in 4 rounds
- Latest Funding Round$55M (USD), Series A
Jan 2026
- InvestorsYK Bioventures
& 14 more
- Employee Count21
Products & Services of Think Bioscience
Think Bioscience offers a comprehensive portfolio of products and services, including Small-Molecule Drugs and Synthetic Biology Platform.
Develops drugs targeting challenging biomolecular mechanisms via synthetic biology techniques.
Platform for uncovering novel biomolecular engagement in drug research and development.
Funding Insights of Think Bioscience
Think Bioscience has successfully raised a total of $78M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $55 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $78M
- Total Rounds 4
- Last Round Series A — $55M
- First Round $255,937
(Dec 2020)
- Investors Count 15
All 4 funding rounds of Think Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $55M | Series A | – | Regeneron Ventures, Janus Henderson Investors | |
| May 2024 | $6M | Seed | – | – | |
| Aug 2022 | $17M | Seed | – | Innovation Endeavors, Xora Innovation | |
| Dec 2020 | $255,937 | Grant | – | – |
15 investors in total: 14 institutional and 1 angel.
Investors in Think Bioscience
Think Bioscience has secured backing from 15 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include YK Bioventures, America’s Seed Fund and Innovation Endeavors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | – | seedfund.nsf.gov | Alexandria, United States | |
Early-stage technology investments are targeted by this venture capital firm. | – | innovationendeavors.com | Palo Alto, United States | |
Capital is provided by Xora to deep tech entrepreneurs. | – | xora.vc | - | |
Early-stage startups are supported by AV8 Ventures through investments. | 2021 | av8.vc | Palo Alto, United States | |
Startups are accelerated by academic-backed, sector-agnostic programs. | – | buffgoldventures.com | Boulder, United States | |
- | – | liquidmetalvc.com | - | |
Early-stage impact-driven fintech and healthcare startups are accelerated. | – | wireframevc.com | San Francisco, United States | |
- | – | axialvc.com | - | |
- | – | regeneronventures.com | - | |
- | – | janushenderson.com | - |
Investor details for Think Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Think Bioscience
25 people are tracked at Think Bioscience (6 in leadership, 9 in board & advisors, 10 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
Jerome Fox | Co-Founder & CEO | Leadership |
Philip Jeng | Co-Founder & COO | Leadership |
Matt Traylor | Chief Scientific Officer | Leadership |
Donghua Dai | Director Of Chemistry | Leadership |
Robyn Hamor | Director | Leadership |
Julia Haas | Vp, Chemistry | Leadership |
Jay Keasling | Advisor | Board & advisors |
Donna See | Board Member | Board & advisors |
Nick Saccomano | Advisor | Board & advisors |
Larry Burgess | Advisor | Board & advisors |
David Chantry | Advisor | Board & advisors |
Stan Lapidus | Advisor | Board & advisors |
Dirk Trauner | Advisor | Board & advisors |
Harvey Blanch | Advisor | Board & advisors |
Ryan Gill | Advisor | Board & advisors |
Solomon Wilcox | Research Technician | Team |
Nickles Badger | Research Technician | Team |
Nolan O’connor | Synthetic Biologist | Team |
Tom Foderaro | Senior Analytical Chemist | Team |
Jessica Lee | Synthetic Biologist | Team |
5 more people are available in the full profile.
Complete people profiles for Think Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Think Bioscience
3 dated milestones of Think Bioscience across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Think Bioscience is founded.
- Funding First funding round of $256K.
- Funding Latest funding round, Series A, of $55.0M.
Competitors of Think Bioscience
Think Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amyris.com | 2003 | Emeryville, United States | $487.2M | 747 | Developer of renewable products for industrial solutions | |
| syngenta.com | 2000 | Basel, Switzerland | – | – | Crop protection solutions and hybrid seeds are provided for farming. | |
| askbio.com | 2001 | Durham, United States | $235M | – | Gene and protein therapies are developed for treating various diseases. | |
| ginkgobioworks.com | 2008 | Boston, United States | $795.75M | 1,218 | Gene editing-based cultured ingredients are provided for agriculture. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| twistbioscience.com | 2013 | San Francisco, United States | $245.81M | 919 | Synthetic DNA is synthesized via a semiconductor-based platform. | |
| asimov.com | 2017 | Boston, United States | $209.4M | 87 | Provider of integrated suite for advanced genetic design and manufacturing | |
| ardelyx.com | 2007 | Fremont, United States | $61.1M | 37 | Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of Think Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Think Bioscience
The website of Think Bioscience (thinkbioscience.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 56.7% vs previous month
Latest news on Think Bioscience
Complete news archive for Think Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Think Bioscience
10 companies that operate in the same segment as Think Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Think Bioscience
Think Bioscience was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Think Bioscience is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Jerome Fox is the current CEO of Think Bioscience. They have also founded this company.
Think Bioscience is a funded company, having raised a total of $78M across 4 funding rounds to date. The company's 1st funding round was a Grant of $255.94K, raised on Dec 2020.
Think Bioscience has 21 employees.
Think Bioscience was founded in 2019 and is headquartered in Boulder, United States. A synthetic biology platform is offered by the company within the biotechnology sector, where applied microbiology, enzymology, and data science are integrated to create small-molecule therapeutics. Focus is placed on targeting difficult-to-drug proteins, supporting drug development operations through this interdisciplinary approach.
Think Bioscience offers Small-Molecule Drugs and Synthetic Biology Platform.
Think Bioscience has 15 investors. Key investors include YK Bioventures, America’s Seed Fund, Innovation Endeavors, Xora, and AV8 Ventures.
Think Bioscience operates through Think Bioscience, Inc..